Approval Investment Portfolios

Pharmaceuticals
SciSparc Advances with FDA Approval on Phase IIb Clinical Trial for Tourette Syndrome Therapy Sep 30, 2024
Companies
Zydus Gains USFDA Approval for Enzalutamide Capsules, Positive Signal for Investors Sep 29, 2024
Pharmaceuticals
Sanofi's Dupixent Becomes First Biologic Approved in the US for COPD With Eosinophilic Phenotype Sep 28, 2024
Companies
First National Corporation and Touchstone Bankshares, Inc. Secure Regulatory Nods for Merger Aug 9, 2024
Pharmaceuticals
Glenmark Pharma Secures USFDA Approval for Heartburn Medicine Jun 12, 2024
Companies
Vedanta Limited Moves Forward with Demerger as Key Creditors Approve Jun 7, 2024
Finance
Shareholders Greenlight IDFC Ltd and IDFC First Bank Merger May 19, 2024
Pharmaceuticals
FDA Approves IMDelltra™ (Tarlatamab-DLLe), a Novel T-Cell Engager Therapy for Extensive-Stage Small Cell Lung Cancer May 17, 2024
Stocks
SEC Approves DWAC and Trump Media Merger Registration, A Potential Financial Windfall for Trump Despite Legal Woes Feb 17, 2024
Companies
WildBrain Shareholders Elect Directors and Greenlight Proposals at Annual Meeting Dec 15, 2023